港股異動丨新世界發展(0017.HK)跌逾4% 柏傲莊III部分混凝土未達設計要求需拆卸重建
格隆匯7月8日丨新世界發展(0017.HK)跌逾4%,報38.3港元,總市值971億港元。公司於大圍站上蓋物業項目柏傲莊III牆身底座混凝土未達設計要求,新世界擬拆卸柏傲莊III第1座及第8座重建,受重建影響的柏傲莊III買家涉846户。交銀國際聯席董事謝騏聰認為,柏傲莊III事件導致柏傲莊III延遲交樓,必定會影響入帳日期,但新世界的工程結構造成的損失應可向承建商追討,而且柏傲莊III事件並不代表新世界對工程要求及質量監控有問題,反而是有質量監控,才在起樓初樓發現事件,但估計事件會導致新世界股價跟隨大市回落,料跌至約38至39港元水平。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.